Global study identifies markers for the five clinical stages of Parkinson's disease
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
Oklahoma Medical Research Foundation receives $3 million grant for Parkinson's research
The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...
Hosted on MSN4d
2 Types of Body Fat Are Now Linked to Dementia, Parkinson’s Risk
Carrying excess fat in your arms and belly might put you at higher risk for Alzheimer’s disease and Parkinson’s disease, ...
Early-onset Parkinson’s disease: Woman diagnosed at 27 reveals the warning signs
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...
Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
WFMZ-TV9d
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
GLP-1 drugs like Ozempic do not slow Parkinson's disease, study finds The trial showed no benefit in symptoms or brain scans Experts say more research is needed before using these drugs for brain ...
KTBS9d
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found that a drug in the same class ...